TWD 16.15
(0.31%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 28.11 Million TWD | -6.86% |
2022 | 30.18 Million TWD | -2.41% |
2021 | 30.93 Million TWD | 79.0% |
2020 | 17.28 Million TWD | 9.55% |
2019 | 15.77 Million TWD | 2815.71% |
2018 | 541 Thousand TWD | 81.54% |
2017 | 298 Thousand TWD | 0.0% |
2016 | - TWD | -100.0% |
2015 | 578 Thousand TWD | 863.33% |
2014 | 60 Thousand TWD | 1100.0% |
2013 | 5000.00 TWD | -99.72% |
2012 | 1.81 Million TWD | 0.0% |
2011 | - TWD | -100.0% |
2010 | 50 Thousand TWD | 0.0% |
2009 | - TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 26.9 Million TWD | -4.32% |
2024 Q2 | 24.05 Million TWD | -10.57% |
2023 Q3 | 30.7 Million TWD | 23.76% |
2023 Q4 | 28.11 Million TWD | -8.44% |
2023 FY | 28.11 Million TWD | -6.86% |
2023 Q1 | 27.75 Million TWD | -8.05% |
2023 Q2 | 24.81 Million TWD | -10.61% |
2022 Q3 | 23.07 Million TWD | -11.69% |
2022 Q2 | 26.13 Million TWD | -7.88% |
2022 FY | 30.18 Million TWD | -2.41% |
2022 Q1 | 28.36 Million TWD | -8.3% |
2022 Q4 | 30.18 Million TWD | 30.82% |
2021 Q1 | 38.43 Million TWD | 122.42% |
2021 Q2 | 36.25 Million TWD | -5.67% |
2021 FY | 30.93 Million TWD | 79.0% |
2021 Q3 | 33.34 Million TWD | -8.04% |
2021 Q4 | 30.93 Million TWD | -7.22% |
2020 FY | 17.28 Million TWD | 9.55% |
2020 Q3 | 20.48 Million TWD | -17.6% |
2020 Q1 | 14.42 Million TWD | -8.56% |
2020 Q2 | 24.85 Million TWD | 72.34% |
2020 Q4 | 17.28 Million TWD | -15.63% |
2019 Q1 | 23.28 Million TWD | 4204.62% |
2019 Q3 | 18.76 Million TWD | -9.38% |
2019 Q4 | 15.77 Million TWD | -15.93% |
2019 FY | 15.77 Million TWD | 2815.71% |
2019 Q2 | 20.7 Million TWD | -11.09% |
2018 Q2 | 496 Thousand TWD | -27.27% |
2018 Q3 | 399 Thousand TWD | -19.56% |
2018 Q4 | 541 Thousand TWD | 35.59% |
2018 Q1 | 682 Thousand TWD | 128.86% |
2018 FY | 541 Thousand TWD | 81.54% |
2017 Q1 | 7000.00 TWD | 0.0% |
2017 FY | 298 Thousand TWD | 0.0% |
2017 Q4 | 298 Thousand TWD | 26.81% |
2017 Q3 | 235 Thousand TWD | 2837.5% |
2017 Q2 | 8000.00 TWD | 14.29% |
2016 Q2 | 25 Thousand TWD | -96.62% |
2016 Q1 | 739 Thousand TWD | 27.85% |
2016 FY | - TWD | -100.0% |
2016 Q3 | 21 Thousand TWD | -16.0% |
2016 Q4 | - TWD | -100.0% |
2015 Q2 | - TWD | -100.0% |
2015 FY | 578 Thousand TWD | 863.33% |
2015 Q4 | 578 Thousand TWD | 0.0% |
2015 Q3 | - TWD | 0.0% |
2015 Q1 | 148 Thousand TWD | 146.67% |
2014 Q2 | 10 Thousand TWD | 100.0% |
2014 Q1 | 5000.00 TWD | 0.0% |
2014 Q3 | 60 Thousand TWD | 500.0% |
2014 Q4 | 60 Thousand TWD | 0.0% |
2014 FY | 60 Thousand TWD | 1100.0% |
2013 Q1 | 5000.00 TWD | -99.72% |
2013 Q3 | 300 Thousand TWD | 500.0% |
2013 Q2 | 50 Thousand TWD | 900.0% |
2013 FY | 5000.00 TWD | -99.72% |
2013 Q4 | 5000.00 TWD | -98.33% |
2012 Q2 | 280 Thousand TWD | 0.0% |
2012 FY | 1.81 Million TWD | 0.0% |
2012 Q1 | - TWD | 0.0% |
2012 Q4 | 1.81 Million TWD | 17.28% |
2012 Q3 | 1.54 Million TWD | 451.79% |
2011 Q2 | 362 Thousand TWD | -93.25% |
2011 Q1 | 5.35 Million TWD | 10618.0% |
2011 Q3 | 6.21 Million TWD | 1615.75% |
2011 Q4 | - TWD | -100.0% |
2011 FY | - TWD | -100.0% |
2010 FY | 50 Thousand TWD | 0.0% |
2010 Q4 | 50 Thousand TWD | 0.0% |
2009 FY | - TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Grape King Bio Ltd | 192.92 Million TWD | 85.427% |
Standard Chem & Pharm CO., LTD. | 1.08 Billion TWD | 97.402% |
Maywufa Company Ltd. | 442.66 Million TWD | 93.649% |
ScinoPharm Taiwan, Ltd. | 621.1 Million TWD | 95.473% |
Lotus Pharmaceutical Co., Ltd. | 11.58 Billion TWD | 99.757% |
LIWANLI Innovation Co., Ltd. | 2.63 Million TWD | -966.578% |
YungShin Global Holding Corporation | 1.23 Billion TWD | 97.732% |
SCI Pharmtech, Inc. | 1.04 Billion TWD | 97.303% |
Formosa Laboratories, Inc. | 4.06 Billion TWD | 99.308% |
PharmaEssentia Corporation | 1.2 Billion TWD | 97.658% |
Bora Pharmaceuticals Co., LTD. | 5 Billion TWD | 99.439% |